Needham & Company Remains Bullish After Meeting with AtriCure (ATRC) Management
Tweet Send to a Friend
Needham & Company reiterated a Buy rating and $23.00 price target on AtriCure Inc. (NASDAQ: ATRC) after hosting meetings with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
